Lipids changes in liver cancer.

Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One (2013) 0.98

[(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma. Mol Imaging Biol (2011) 0.96

The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy (2011) 0.95

The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon (2010) 0.95

Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies. BMC Genomics (2013) 0.87

Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs. MBio (2015) 0.85

A1BG and C3 are overexpressed in patients with cervical intraepithelial neoplasia III. Oncol Lett (2014) 0.80

Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy. J Zhejiang Univ Sci B (2008) 0.78

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer. Saudi Pharm J (2015) 0.75

Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells. J Exp Clin Cancer Res (2017) 0.75

Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients. J Cancer (2016) 0.75

Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver. Biochim Biophys Acta (2016) 0.75

Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy. PLoS One (2017) 0.75

Differential expression of six genes and correlation with fatness traits in a unique broiler population. Saudi J Biol Sci (2015) 0.75

Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice. Cancer Med (2017) 0.75

Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest (2005) 9.09

p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A (1989) 4.80

New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res (2005) 4.47

Molecular physiology of reverse cholesterol transport. J Lipid Res (1995) 3.66

Alcoholic liver disease. Lancet (1995) 2.97

Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem (1999) 2.50

Cancer incidence by levels of cholesterol. JAMA (1981) 2.42

Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33

Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol (1980) 2.06

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05

Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res (1999) 2.03

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs (1994) 2.01

Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis (1988) 1.94

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92

Lipoprotein metabolism. Adv Lipid Res (1975) 1.90

Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst (1986) 1.87

A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer (2005) 1.76

Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst (1987) 1.64

Apolipoprotein E and atherosclerosis. Curr Opin Lipidol (2000) 1.61

Turnover of lipoprotein (a) in man. J Clin Invest (1980) 1.48

Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem (1991) 1.44

The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism. Curr Opin Lipidol (2000) 1.39

Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology (1999) 1.34

Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis (1989) 1.34

Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest (2000) 1.33

Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control (1991) 1.27

The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol (1998) 1.24

Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest (1983) 1.22

Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20

Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med (1985) 1.20

Cell compartmentalization of cholesterol biosynthesis. Ann N Y Acad Sci (1996) 1.19

[Mortality of primary liver cancer in China from 1990 through 1992]. Zhonghua Zhong Liu Za Zhi (1999) 1.19

Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem (2004) 1.17

Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res (1977) 1.16

Receptor-mediated catabolism of homologous low density lipoproteins in cultured pig hepatocytes. J Biol Chem (1981) 1.13

Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine. Proc Natl Acad Sci U S A (1988) 1.09

Mechanisms of cancer cachexia. Hematol Oncol Clin North Am (1991) 1.06

Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem (1994) 1.04

The lipid composition of serum in patients with liver disease. J Clin Invest (1960) 1.04

Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci (2004) 1.02

Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol (1994) 1.01

The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem (2004) 1.00

Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation (2001) 1.00

Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology (1999) 0.99

Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis (2002) 0.98

Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res (1983) 0.98

Hepatocellular carcinoma: the high-risk patient. J Clin Gastroenterol (2002) 0.97

Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med (2005) 0.96

1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol (2000) 0.95

Flux of free fatty acids among host tissues, ascites fluid, and Ehrlich ascites carcinoma cells. J Lipid Res (1974) 0.93

Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochem J (2004) 0.93

Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis. Hepatology (1993) 0.93

Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. Minerva Med (2001) 0.92

Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res (1994) 0.92

Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int (1991) 0.90

Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr Drug Targets (2000) 0.89

Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol (1996) 0.89

Low lipoprotein (a) levels during acute viral hepatitis. Hepatology (1996) 0.89

A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases. Surg Today (1995) 0.89

Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J Nutr Sci Vitaminol (Tokyo) (2004) 0.88

High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). Biochemistry (1996) 0.87

Characterization of a human hepatic receptor for high density lipoproteins. Arteriosclerosis (1985) 0.87

Effects of liver transplantation and resection on lipid parameters: a longitudinal study. Aust N Z J Surg (1996) 0.87

High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J Gastroenterol (2005) 0.87

Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot Essent Fatty Acids (2003) 0.86

Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen. Proc Natl Acad Sci U S A (1992) 0.86

The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly. Arterioscler Thromb Vasc Biol (1995) 0.86

Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein. Hepatology (1993) 0.86

Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH7777 rat hepatoma cultures. Biochem J (1992) 0.85

Differential tissue-specific expression of human apoA-I and apoA-II. J Lipid Res (1991) 0.85

Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells. Life Sci (2001) 0.85

The importance of free fatty acid in tumor nutrition. Cancer Res (1967) 0.85

High-density lipoprotein cholesterol and liver disease. Hepatology (1983) 0.84

Lipid and apolipoprotein changes after orthotopic liver transplantation for end-stage liver diseases. Clin Chim Acta (1992) 0.84

Lipoprotein (a) serum levels in patients with hepatocarcinoma. Clin Chim Acta (1997) 0.84

Estimation of dolichol and cholesterol synthesis in microsomes and peroxisomes isolated from rat liver. FEBS Lett (1995) 0.82

Bile salt metabolism. I. The physiology of bile salts. Aust N Z J Med (1977) 0.82

Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles. J Control Release (1998) 0.82

Protein kinase C-mediated tyrosine phosphorylation of paxillin and focal adhesion kinase requires cytoskeletal integrity and is uncoupled to mitogen-activated protein kinase activation in human hepatoma cells. J Biomed Sci (2001) 0.82

Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line. Int J Biochem Cell Biol (2002) 0.82

Utilization and preferred metabolic pathway of ketone bodies for lipid synthesis by isolated rat hepatoma cells. Am J Physiol (1995) 0.81

Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy. Wound Repair Regen (2002) 0.81

Lack of effect of acute alcohol ingestion on plasma lipids. Clin Chem (1991) 0.81

Lipoprotein(a) in cirrhosis. A new index of liver functions? Curr Med Res Opin (1996) 0.81

Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells. Int J Biochem Cell Biol (2005) 0.80

Effect of dietary fat on diethylnitrosamine induced hepatocarcinogenesis in Wistar rats. Cancer Lett (1995) 0.80

Tumor proteolipids. Prog Biochem Pharmacol (1975) 0.80

Association of apolipoprotein E with the low density lipoprotein receptor: demonstration of its co-operativity on lipid microemulsion particles. J Biochem (1989) 0.80

Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis. Gastroenterol Jpn (1988) 0.80

Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis. J Clin Chem Clin Biochem (1986) 0.80

Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J Lipid Res (1997) 0.80

Apolipoproteins and lipoproteins of human plasma: significance in health and in disease. Adv Lipid Res (1983) 0.79

Pathway of cholesterol efflux from human hepatoma cells. Biochim Biophys Acta (1995) 0.79

Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture. Atherosclerosis (1998) 0.79

Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Clin Endocrinol (Oxf) (1998) 0.79

Antibodies against high-density lipoprotein binding proteins enhance high-density lipoprotein uptake but do not affect cholesterol efflux from rat hepatoma cells. Int J Biochem Cell Biol (1997) 0.79

Epsilon PKC acts like a marker of progressive malignancy in rat liver, but fails to enhance tumorigenesis in rat hepatoma cells in culture. Biochem Biophys Res Commun (1996) 0.79

Growth inhibition of human hepatoma cells (HepG2) by polyunsaturated fatty acids. Protection by albumin and vitamin E. Acta Physiol Scand (1992) 0.79

Treatment of nonresectable hepatocellular carcinoma: review of the literature and meta-analysis. Adv Ther (1995) 0.79

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem (2006) 3.24

Suppression of RNA interference by adenovirus virus-associated RNA. J Virol (2005) 2.29

Identification of bacteria and bacteria-associated chemical cues that mediate oviposition site preferences by Aedes aegypti. Proc Natl Acad Sci U S A (2008) 1.88

The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther (2010) 1.83

Four-color DNA sequencing with 3'-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides. Proc Natl Acad Sci U S A (2008) 1.64

Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res (2005) 1.62

Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg (2015) 1.55

Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology (2009) 1.48

Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China. Urology (2003) 1.47

Diethyl 3,3'-(phenyl-methyl-ene)bis-(1H-indole-2-carboxyl-ate). Acta Crystallogr Sect E Struct Rep Online (2012) 1.42

SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet (2011) 1.41

An improved elastase-based method to create a saccular aneurysm rabbit model. Br J Neurosurg (2013) 1.40

National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis (2013) 1.39

Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer. Anticancer Res (2009) 1.38

CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol (2009) 1.36

MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol (2010) 1.32

Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem (2003) 1.28

Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res (2006) 1.25

Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis (2006) 1.23

Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One (2013) 1.19

Dimethyl 3,3'-(phenyl-methyl-ene)bis-(1H-indole-2-carboxyl-ate). Acta Crystallogr Sect E Struct Rep Online (2013) 1.18

Mining protein sequences for motifs. J Comput Biol (2002) 1.15

Post-percutaneous nephrolithotomy septic shock and severe hemorrhage: a study of risk factors. Urol Int (2012) 1.14

Soft modes and elasticity of nearly isostatic lattices: randomness and dissipation. Phys Rev Lett (2010) 1.14

Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation (2006) 1.13

Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem (2003) 1.13

Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res (2010) 1.12

Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab (2006) 1.11

KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans. Mol Hum Reprod (2007) 1.11

Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res (2009) 1.11

Autophagy regulates hypoxia-induced osteoclastogenesis through the HIF-1α/BNIP3 signaling pathway. J Cell Physiol (2012) 1.09

Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro. Biochem Biophys Res Commun (2008) 1.06

The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget (2014) 1.06

Diversity of bacterial communities in container habitats of mosquitoes. Microb Ecol (2008) 1.06

Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Res (2010) 1.05

The expression of microRNA-203 during human skin morphogenesis. Exp Dermatol (2010) 1.04

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis (2012) 1.03

A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo. Int J Cancer (2013) 1.02

Oviposition responses of the mosquitoes Aedes aegypti and Aedes albopictus to experimental plant infusions in laboratory bioassays. J Chem Ecol (2010) 1.02

miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. Carcinogenesis (2013) 1.01

Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro. Biochim Biophys Acta (2007) 1.01

Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats. J Neuroinflammation (2012) 1.01

Apolipoprotein M. Lipids Health Dis (2004) 1.00

Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma? Cardiovasc Res (2013) 1.00

Photoluminescence and low-threshold lasing of ZnO nanorod arrays. Opt Express (2012) 1.00

AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: a possible role for AMPK. Biochem Biophys Res Commun (2005) 0.99

Heat transport in model jammed solids. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.98

Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients. World J Gastroenterol (2010) 0.98

Thermal vestige of the zero-temperature jamming transition. Nature (2009) 0.98

MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol (2012) 0.96

Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J Gastroenterol (2010) 0.95

Airborne brake wear debris: size distributions, composition, and a comparison of dynamometer and vehicle tests. Environ Sci Technol (2003) 0.94

Review of Chinese clinical trials on CIK cell treatment for malignancies. Clin Transl Oncol (2012) 0.94

Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation (2010) 0.94

MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA. J Cell Physiol (2015) 0.94

IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line. Anticancer Res (2009) 0.93

Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis (2012) 0.92

Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim Biophys Acta (2004) 0.92

Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue. Oral Oncol (2009) 0.92

Efficacy of endoscopic therapy for gastrointestinal bleeding from Dieulafoy's lesion. World J Gastroenterol (2011) 0.91

Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91

Liposarcoma of the spermatic cord mimicking a left inguinal hernia: a case report and literature review. World J Surg Oncol (2013) 0.91

Inhibitory effects of reserpine and carbonyl cyanide m-chloro-phenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii. Chin Med J (Engl) (2005) 0.91

Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen. Chin Med J (Engl) (2004) 0.90

Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem (2009) 0.90

Expression pattern of apolipoprotein M during mouse and human embryogenesis. Acta Histochem (2004) 0.90

Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation. J Biol Chem (2009) 0.90

5-Bromo-N-methyl-pyrimidin-2-amine. Acta Crystallogr Sect E Struct Rep Online (2011) 0.90

miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells. Dig Dis Sci (2012) 0.90

Accounting for signal loss due to dephasing in the correction of distortions in gradient-echo EPI via nonrigid registration. IEEE Trans Med Imaging (2007) 0.90

Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in mice. Clin Cancer Res (2009) 0.89

Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. Biochem Biophys Res Commun (2002) 0.89

The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Clin Lab (2010) 0.89

A modified sagittal spine postural classification and its relationship to deformities and spinal mobility in a chinese osteoporotic population. PLoS One (2012) 0.88

Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China. World J Surg Oncol (2013) 0.88

Clinical significance of CD44 variants expression in colorectal cancer. Tumori (2013) 0.88

Expression and localization of apolipoprotein M in human colorectal tissues. Lipids Health Dis (2010) 0.87

Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases. Lipids Health Dis (2008) 0.87

[Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices]. Zhonghua Yi Xue Za Zhi (2009) 0.87

Understanding the low-frequency quasilocalized modes in disordered colloidal systems. Phys Rev Lett (2012) 0.87

MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumour Biol (2015) 0.86

E. coli pneumonia induces CD18-independent airway neutrophil migration in the absence of increased lung vascular permeability. Am J Physiol Lung Cell Mol Physiol (2003) 0.86

Narrow-band imaging in the diagnosis of early esophageal cancer and precancerous lesions. Chin Med J (Engl) (2009) 0.86

LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. J Proteome Res (2014) 0.86

Expression of MMP-10 in lung cancer. Anticancer Res (2007) 0.86

Increased expression of Syne1/nesprin-1 facilitates nuclear envelope structure changes in embryonic stem cell differentiation. Dev Dyn (2011) 0.86

Facilitated diffusion of acetonitrile revealed by quantitative breath analysis using extractive electrospray ionization mass spectrometry. Sci Rep (2013) 0.85

The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun (2011) 0.85

Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1. Clin Cancer Res (2007) 0.85

Interleukin-1 inhibits Sox9 and collagen type II expression via nuclear factor-kappaB in the cultured human intervertebral disc cells. Chin Med J (Engl) (2009) 0.85

Expression of apolipoprotein M in human hepatocellular carcinoma tissues. Acta Histochem (2009) 0.85

NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.84

Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. World J Gastroenterol (2004) 0.84

The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis. Pathol Res Pract (2013) 0.83

Expression of costimulatory molecule B7-H4 in human malignant tumors. Onkologie (2012) 0.83

Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation (2006) 0.83

Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells. Biochim Biophys Acta (2005) 0.83

Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring. J Dig Dis (2011) 0.82

Clinical significance of serum ferritin in elderly patients with primary lung carcinoma. Tumour Biol (2014) 0.82

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. Int J Hyperthermia (2010) 0.82